Abstract
The N-methyl-D-aspartate (NMDA) receptor plays a role in the pathophysiology of schizophrenia, and the NMDA receptor is one of the most attractive therapeutic targets for this disease. In this symposium, the four speakers had discussed the role of NMDA receptor in the pathophysiology of schizophrenia and the possibility of NMDA receptor as a therapeutic target.
